# Mitsuhiko Noda

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mitsuhiko-noda/

## Facts

| Field | Value |
| --- | --- |
| Citations | 23,917 |
| Field | Diabetes, Cardiovascular Risks, and Lipoproteins |
| h-index | 70 |
| i10-index | 256 |
| Last Known Institution | JGC (Japan) |
| OpenAlex ID | https://openalex.org/A5017888890 |
| ORCID iD | 0000-0003-0413-4631 |
| Works | 449 |

## Researcher papers

Showing 12 of 16.

- [Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase](https://scholariq.org/papers/adiponectin-stimulates-glucose-utilization-and-fatty-acid-oxidation-by/)
- [International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values](https://scholariq.org/papers/international-clinical-harmonization-of-glycated-hemoglobin-in-japan-from-japan/)
- [What has made the population of Japan healthy?](https://scholariq.org/papers/what-has-made-the-population-of-japan-healthy/)
- [Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males](https://scholariq.org/papers/prevention-of-type-2-diabetes-by-lifestyle-intervention-a-japanese-trial-in-igt/)
- [Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis](https://scholariq.org/papers/cancer-risk-in-diabetic-patients-treated-with-metformin-a-systematic-review-and/)
- [Japanese Clinical Practice Guideline for Diabetes 2019](https://scholariq.org/papers/japanese-clinical-practice-guideline-for-diabetes-2019/)
- [Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis](https://scholariq.org/papers/severe-hypoglycaemia-and-cardiovascular-disease-systematic-review-and-meta/)
- [Development of a Database of Health Insurance Claims: Standardization of Disease Classifications and Anonymous Record Linkage](https://scholariq.org/papers/development-of-a-database-of-health-insurance-claims-standardization-of-disease/)
- [Japanese Clinical Practice Guideline for Diabetes 2019](https://scholariq.org/papers/japanese-clinical-practice-guideline-for-diabetes-2019-2/)
- [Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial](https://scholariq.org/papers/effect-of-an-intensified-multifactorial-intervention-on-cardiovascular-outcomes/)
- [Adult Mortality Attributable to Preventable Risk Factors for Non-Communicable Diseases and Injuries in Japan: A Comparative Risk Assessment](https://scholariq.org/papers/adult-mortality-attributable-to-preventable-risk-factors-for-non-communicable/)
- [Low-Carbohydrate Diets and All-Cause Mortality: A Systematic Review and Meta-Analysis of Observational Studies](https://scholariq.org/papers/low-carbohydrate-diets-and-all-cause-mortality-a-systematic-review-and-meta/)

## Researcher topics

- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)

## Researcher university

- [JGC (Japan)](https://scholariq.org/institutions/jgc-japan/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.